Trial intelligence / Profile preview

Nalbuphine versus fentanyl infusion during lumbar spine fixation surgery under TIVA

PACTR202504661778147Phase 2Completed

Sponsor
Kasr Al Ainy Hospital
Start
Dec 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of nalbuphine and fentanyl in anaesthesia (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Time to extubation. Started Dec 2024; status: completed.

02

Drugs

nalbuphinefentanyl
03

Conditions

anaesthesia

Beyond the preview

Go deeper on PACTR202504661778147.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202504661778147.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call